hydroxyflutamide has been researched along with nitrogenase stabilizing-protective protein, bacteria in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Dence, CS; Jenks, C; Katzenellenbogen, JA; Parent, EE; Sharp, TL; Welch, MJ | 1 |
| Hashimoto, Y; Imai, K; Miyachi, H; Tanatani, A; Wakabayashi, K | 1 |
| Endo, Y; Fujii, S; Goto, T; Ohta, K; Ohta, S | 1 |
| Ihalainen, JA; Laatikainen, R; Oravilahti, T; Palvimo, JJ; Peräkylä, M; Poutiainen, PK; Pulkkinen, JT | 1 |
| Fujii, S; Hashimoto, Y; Hirano, T; Inoue, K; Ishigami-Yuasa, M; Kagechika, H; Kanai, M; Kawachi, E; Matsumura, M; Mori, S; Tanatani, A; Urushibara, K; Yura, K | 1 |
| Wang, S; Xiang, W | 1 |
1 review(s) available for hydroxyflutamide and nitrogenase stabilizing-protective protein, bacteria
| Article | Year |
|---|---|
Therapeutic Strategies to Target the Androgen Receptor.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen | 2022 |
5 other study(ies) available for hydroxyflutamide and nitrogenase stabilizing-protective protein, bacteria
| Article | Year |
|---|---|
Synthesis and biological evaluation of [18F]bicalutamide, 4-[76Br]bromobicalutamide, and 4-[76Br]bromo-thiobicalutamide as non-steroidal androgens for prostate cancer imaging.
Topics: Androgen Antagonists; Anilides; Animals; Bromine Radioisotopes; Fluorine Radioisotopes; Isotope Labeling; Ligands; Male; Mice; Neoplasm Transplantation; Nitriles; Prostatic Neoplasms; Radioligand Assay; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Stereoisomerism; Structure-Activity Relationship; Tissue Distribution; Tosyl Compounds | 2007 |
4-(Anilino)pyrrole-2-carboxamides: Novel non-steroidal/non-anilide type androgen antagonists effective upon human prostate tumor LNCaP cells with mutated nuclear androgen receptor.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Cell Line, Tumor; Humans; Male; Mutation; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Binding; Pyrroles; Receptors, Androgen | 2008 |
Design and synthesis of androgen receptor full antagonists bearing a p-carborane cage: promising ligands for anti-androgen withdrawal syndrome.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Antineoplastic Agents, Hormonal; Boranes; Cell Line, Tumor; Cell Proliferation; Drug Design; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Receptors, Androgen | 2010 |
Design, synthesis, and biological evaluation of nonsteroidal cycloalkane[d]isoxazole-containing androgen receptor modulators.
Topics: Animals; Chemistry Techniques, Synthetic; Chlorocebus aethiops; COS Cells; Cycloparaffins; Drug Design; Isoxazoles; Models, Molecular; Nonsteroidal Anti-Androgens; Protein Conformation; Receptors, Androgen; Structure-Activity Relationship | 2012 |
Design and synthesis of 4-benzyl-1-(2H)-phthalazinone derivatives as novel androgen receptor antagonists.
Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Male; Mice; Models, Molecular; Molecular Structure; Phthalazines; Prostatic Neoplasms; Receptors, Androgen; Structure-Activity Relationship | 2015 |